GSK boosts stake in Aspen
May 12, 2009Sales and Marketing GSK, generics
GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …
Working Life: Nick Rodgers
May 12, 2009Sales and Marketing WL, Working Life, marketing, product manager
How did you find your way into your current role?I started my pharma career at Schering Healthcare as a representative …
UK a step closer to new swine flu vaccine
May 11, 2009Research and Development NHS, h1n1
The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …
GSK claims superiority for Cervarix in head-to-head trial
May 11, 2009Research and Development, Sales and Marketing GSK, vaccines
GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
Cmed and Tessella join forces on adaptive trials
May 11, 2009Research and Development Cmed, digi
UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …
Sanofi hikes flu vaccine capacity with new US plant
May 11, 2009Manufacturing and Production Sanofi-Aventis, h1n1
Sanofi-Aventis has been given a green light for a new $150 million flu vaccine manufacturing plant in the US that …
Advertising regulator clears ‘dead rat’ cinema ad
May 11, 2009Sales and Marketing counterfeits
Pfizer's hard-hitting advert about the dangers of using counterfeit medicines did not breach advertising regulations, according to the Advertising Standards …
Allergan closes doors on Irish plant
May 8, 2009Manufacturing and Production Allergan
US drugmaker Allergan has brought the curtain down on its manufacturing facility in Arklow, Ireland, months ahead of schedule. The …
Pharma must go further with its collaborations
May 8, 2009Research and Development, Sales and Marketing pwC, strategy
Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
Servier signs drug discovery deal with Vernalis
May 7, 2009Research and Development, Sales and Marketing Servier, Vernalis
Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
NICE rejects Nexavar for liver cancer
May 7, 2009Research and Development, Sales and Marketing Bayer, NICE, Nexavar
NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
Avastin approved for aggressive brain tumour
May 7, 2009Sales and Marketing GBM, avastin
Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …
Novo Nordisk plans summer launches for new diabetes drug
May 7, 2009Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
NHS should be ‘jewel in the crown’ for UK biotech
May 7, 2009Research and Development NICE
The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …
Sanofi-Aventis makes 200m euro push into antibodies
May 7, 2009Manufacturing and Production Sanofi-Aventis, biologicals
Sanofi-Aventis will spend 200 million euros to convert one of its facilities near Paris into a biotechnology facility which is …
Building better relations with tomorrow’s doctors
May 6, 2009Sales and Marketing doctors, industry relations
A huge amount of time and money is spent by the pharma industry on interacting with the medical community and …
Bayer launches UK television ads for its morning-after pill
May 6, 2009Sales and Marketing Bayer
Bayer Schering Pharma has launched a television advertising campaign for its morning-after pill Levonelle One Step in the UK. The …
Pharma manufacturing: news in brief
May 6, 2009Manufacturing and Production Pfizer
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including Pfizer's increased adoption of contract manufacturing and facility …
Ranbaxy woes continue with antibiotic recall
May 6, 2009Sales and Marketing Ranbaxy, US
Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …
Latest content
